(Q29347530)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134041%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

title

Mutation in ADORA1 identified as likely cause of early-onset parkinsonism and cognitive dysfunction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134041%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

main subject

Adenosine A1 receptor

1 reference

GOA release 2020-03-11

2 references

parkinsonian syndrome

1 reference

Elham Jaberi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134041%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Mohammad Rohani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134041%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Gholam Ali Shahidi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134041%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Ehsan Arefian

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134041%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Masoud Soleimani

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134041%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Abolfazl Moghadam

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134041%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Mohsen Karimi Arzenani

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134041%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Farid Keramatian

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134041%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Brandy Klotzle

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134041%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Jian-Bing Fan

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134041%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Casey Turk

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134041%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Elahe Elahi

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134041%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

language of work or name

English

0 references

publication date

2 May 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134041%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134041%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134041%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134041%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

page(s)

1004-1011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134041%20AND%20SRC:MED&resulttype=core&format=json

Understanding the molecular causes of Parkinson's disease.

3 April 2020

cites work

1 reference

Parkinson's disease: mechanisms and models

21 January 2018

1 reference

A clinic-based screening of mutations in exons 31, 34, 35, 41, and 48 of LRRK2 in Iranian Parkinson's disease patients.

21 January 2018

1 reference

Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays

21 January 2018

1 reference

PRKN, DJ-1, and PINK1 screening identifies novel splice site mutation in PRKN and two novel DJ-1 mutations.

21 January 2018

1 reference

Identification of p.Gln858* in ATP13A2 in two EOPD patients and presentation of their clinical features.

21 January 2018

1 reference

Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase

21 January 2018

1 reference

Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes

21 January 2018

1 reference

A general framework for estimating the relative pathogenicity of human genetic variants

21 January 2018

1 reference

Screening for Mild Cognitive Impairment in Parkinson's Disease: Comparison of the Italian Versions of Three Neuropsychological Tests

21 January 2018

1 reference

Mutations in HPCA cause autosomal-recessive primary isolated dystonia

21 January 2018

1 reference

Scanning mutagenesis in a yeast system delineates the role of the NPxxY(x)(5,6)F motif and helix 8 of the adenosine A(2B) receptor in G protein coupling

21 January 2018

1 reference

Truncation of the A1 adenosine receptor reveals distinct roles of the membrane-proximal carboxyl terminus in receptor folding and G protein coupling

21 January 2018

1 reference

Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease

21 January 2018

1 reference

Genome-wide association study reveals genetic risk underlying Parkinson's disease

21 January 2018

1 reference

Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus

21 January 2018

1 reference

An independent replication of PARK16 in Asian samples

21 January 2018

1 reference

Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population

21 January 2018

1 reference

Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs

21 January 2018

1 reference

Normal and abnormal functions of adenosine receptors in the central nervous system revealed by genetic knockout studies

21 January 2018

1 reference

Control and function of the homeostatic sleep response by adenosine A1 receptors

21 January 2018

1 reference

Adenosine A2A receptor interactions with receptors for other neurotransmitters and neuromodulators.

21 January 2018

1 reference

Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss

21 January 2018

1 reference

Mice lacking the adenosine A1 receptor have normal spatial learning and plasticity in the CA1 region of the hippocampus, but they habituate more slowly.

21 January 2018

1 reference

Adenosine A2 receptor-mediated excitatory actions on the nervous system

21 January 2018

1 reference

Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition.

21 January 2018

1 reference

Structure and function of adenosine receptors and their genes.

21 January 2018

1 reference

Agonist activity of 2- and 5'-substituted adenosine analogs and their N6-cycloalkyl derivatives at A1- and A2-adenosine receptors coupled to adenylate cyclase

21 January 2018

1 reference

Heterodimerization of g protein-coupled receptors: specificity and functional significance.

21 January 2018

1 reference

Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function.

21 January 2018

1 reference

Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors

21 January 2018

1 reference

A1R-A2AR heteromers coupled to Gs and G i/0 proteins modulate GABA transport into astrocytes.

21 January 2018

1 reference

A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis.

21 January 2018

1 reference

Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia

21 January 2018

1 reference

Distribution, biochemistry and function of striatal adenosine A2A receptors

21 January 2018

1 reference

Targeting adenosine A2A receptors in Parkinson's disease

21 January 2018

1 reference

Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications

21 January 2018

1 reference

Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease

21 January 2018

1 reference

Adenosine A2A antagonists as neurotherapeutics: crossing the bridge

21 January 2018

1 reference

Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

21 January 2018

1 reference

Adenosine A(2A) receptor antagonist treatment of Parkinson's disease

21 January 2018

1 reference

Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD.

21 January 2018

1 reference

Adenosine, adenosine A 2A antagonists, and Parkinson's disease.

21 January 2018

1 reference

Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005).

21 January 2018

1 reference

A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease

21 January 2018

1 reference

Tissue distribution of adenosine receptor mRNAs in the rat.

21 January 2018

1 reference

Modulation of Ca2+-currents by sequential and simultaneous activation of adenosine A1 and A 2A receptors in striatal projection neurons.

21 January 2018

1 reference

Prevalence of Parkinson's disease in the elderly: The Rotterdam Study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.26627

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27134041%20AND%20SRC:MED&resulttype=core&format=json

release_kgag4uuqs5fhhkgi5zwojvwv3m

3 April 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kgag4uuqs5fhhkgi5zwojvwv3m

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference